Xinlong Zang

8PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 16, 2024
Stimulus Responsive Nanocarrier for Enhanced Antitumor Responses Against Hepatocellular Carcinoma.

Deteng Zhang, Jinxiao Song, Zhenghui Jing

|Jul 18, 2023
Codelivery of Que and BCL-2 siRNA with Lipid-Copolymer Hybrid Nanocomplexes for Efficient Tumor Regression.

Kangkang Li, Xiaohua Cai, Yong Fan

|Mar 29, 2023
ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy.

Jingyi Zhou, Kangkang Li, Xinlong Zang

|Dec 15, 2020
Ischemia Reperfusion Injury: Opportunities for Nanoparticles.

Xinlong Zang, Jingyi Zhou, Xiaoxu Zhang

|Dec 15, 2020
Targeted Delivery of Dasatinib to Deplete Tumor-Associated Macrophages by Mannosylated Mixed Micelles for Tumor Immunotherapy.

Xiaoxu Zhang, Xinlong Zang, Mingxi Qiao

Pageof 2